TSRC, Tob. Sci. Res. Conf., 2021, 74, abstr. 01 (Symposium)

FDA perspective: opportunities for harm reduction

HOLMAN M.

U.S. Food & Drug Administration, Silver Springs, MD, USA

Abstract not available.

Documents

Presentation

Presentations, posters and manuscripts have not been peer-reviewed. Their content engages only the authors and is not the responsibility of CORESTA.